Mitapivat, a novel medicinal agent, represents a promising development in the treatment of blood cell disorders such as pyruvate kinase deficiency (PKD). This unique molecule functions as a potent protein kinase R, boosting its activity and, consequently, enhancing erythropoiesis. Its mechanism of action is believed to ameliorate metabolic abnormal